David Gray
About
David Gray is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, David Gray has authored 135 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 19 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Gray's work include Parkinson's Disease Mechanisms and Treatments (11 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Receptor Mechanisms and Signaling (8 papers). David Gray is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Receptor Mechanisms and Signaling (8 papers). David Gray collaborates with scholars based in United States, United Kingdom and Canada. David Gray's co-authors include A.G. Robiette, K. C. Nicolaou, Jinsung Tae, Scott T. Harrison, Tamsyn Montagnon, K. C. Nicolaou, F. W. Birss, Ralph L. Webb, Sridhar Duvvuri and John R. Kershaw and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.
In The Last Decade
David Gray
129 papers receiving 3.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| David Gray United States | 35 | 1.2k | 683 | 673 | 590 | 352 | 135 | 3.9k | ||
| Kenneth J. Wilson United States | 35 | 503 0.4× | 603 0.9× | 1.5k 2.2× | 142 0.2× | 163 0.5× | 122 | 4.0k | ||
| Carlo Cavallotti Italy | 42 | 575 0.5× | 356 0.5× | 998 1.5× | 956 1.6× | 367 1.0× | 323 | 6.6k | ||
| Gary W. Small United States | 37 | 1.0k 0.9× | 803 1.2× | 1.0k 1.5× | 141 0.2× | 194 0.6× | 181 | 6.9k | ||
| Michiko Takahashi Japan | 61 | 213 0.2× | 284 0.4× | 2.1k 3.2× | 1.1k 1.9× | 914 2.6× | 319 | 13.6k | ||
| J. Doucet France | 44 | 680 0.6× | 502 0.7× | 1.1k 1.6× | 389 0.7× | 60 0.2× | 211 | 5.8k | ||
| Akira Mizuno Japan | 54 | 1.0k 0.9× | 912 1.3× | 854 1.3× | 376 0.6× | 98 0.3× | 466 | 10.4k | ||
| Salvatore Magazù Italy | 37 | 570 0.5× | 406 0.6× | 1.3k 2.0× | 842 1.4× | 84 0.2× | 306 | 5.5k | ||
| Kaoru Nakamura Japan | 42 | 1.6k 1.4× | 967 1.4× | 4.1k 6.0× | 138 0.2× | 344 1.0× | 277 | 6.6k | ||
| Dávid Becker United States | 32 | 672 0.6× | 279 0.4× | 1.4k 2.0× | 371 0.6× | 86 0.2× | 128 | 3.6k | ||
| Klaus Arnold Germany | 46 | 599 0.5× | 1.5k 2.2× | 3.6k 5.3× | 408 0.7× | 198 0.6× | 190 | 6.3k |
Countries citing papers authored by David Gray
Since
Specialization
Citations
This map shows the geographic impact of David Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gray more than expected).
Fields of papers citing papers by David Gray
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gray. The network helps show where David Gray may publish in the future.
Co-authorship network of co-authors of David Gray
This figure shows the co-authorship network connecting the top 25 collaborators of David Gray. A scholar is included among the top collaborators of David Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gray. David Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mirescu, Christian, Borislav Dejanovic, Frederick W. Gergits, et al.. (2024). Pharmacological and functional characterization of the first small molecule TREM2 agonist, VG‐3927, for the treatment of Alzheimer’s disease. Alzheimer s & Dementia. 20(S6).
2.
Lewis, Mechelle M., Lauren J. Van Scoy, Sol De Jesus, et al.. (2023). Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules. 13(5). 829–829.
3.
Isaacson, Stuart, Robert A. Hauser, Rajesh Pahwa, David Gray, & Sridhar Duvvuri. (2023). Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment. Clinical Parkinsonism & Related Disorders. 9. 100212–100212.
4.
Moore, Tara L., Damon Young, Ronald Killiany, et al.. (2021). The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey. Frontiers in Aging Neuroscience. 13. 757850–757850.
5.
Soutschek, Alexander, Rouba Kozak, Sridhar Duvvuri, et al.. (2019). Dopaminergic D1 Receptor Stimulation Affects Effort and Risk Preferences. Biological Psychiatry. 87(7). 678–685.
6.
Gray, David, John Allen, Scot Mente, et al.. (2018). Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nature Communications. 9(1). 674–674.
7.
Sciabola, Simone, Gilles H. Goetz, Guoyun Bai, et al.. (2016). Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network. Bioorganic & Medicinal Chemistry. 24(16). 3513–3520.
8.
Dickel, Michael J., et al.. (2010). Hypnotics Fail to Improve Polysomnographic Quality and Efficacy of CPAP Titration. CHEST Journal. 138(4). 701A–701A.
9.
Gray, David, et al.. (2010). Ranolazine (Ranexa®) in the treatment of chronic stable angina. Advances in Therapy. 27(4). 193–201.
10.
Pettersson, Martin, Brian Campbell, Amy B. Dounay, et al.. (2010). Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 865–868.
11.
Gray, David, et al.. (2009). Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina. Advances in Therapy. 26(2). 127–137.
12.
Gray, David, Brian Campbell, Amy B. Dounay, et al.. (2009). Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(23). 6604–6607.
13.
Xu, Wenjian, David Gray, Shelly A. Glase, & Nancy S. Barta. (2008). Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5550–5553.
14.
Fish, Paul V., Nancy S. Barta, David Gray, et al.. (2008). Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity. Bioorganic & Medicinal Chemistry Letters. 18(15). 4355–4359.
15.
Marriott, Ian, David Gray, Vance G. Fowler, et al.. (2005). Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone. 37(4). 504–512.
16.
Karnon, Jonathan, Alan Brennan, Abdullah Pandor, et al.. (2004). Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK. Current Medical Research and Opinion. 21(1). 101–112.
17.
Passik, Steven D., et al.. (2003). A Retrospective Chart Review of the Use of Olanzapine for the Prevention of Delayed Emesis in Cancer Patients. Journal of Pain and Symptom Management. 25(5). 485–488.
18.
Nicolaou, K. C., David Gray, & Jinsung Tae. (2001). Total Synthesis of Hamigerans: Part 2. Implementation of the Intramolecular Diels–Alder Trapping of Photochemically Generated Hydroxy-o-quinodimethanes; Strategy and Completion of the Synthesis This work was financially supported by the National Institutes of Health (USA) and The Skaggs Institute for Chemical Biology, and grants from Abbott, Amgen, ArrayBiopharma, Boehringer-Ingelheim, Glaxo, Hoffmann-La Roche, DuPont, Merck, Pfizer, and Schering Plough.. Angewandte Chemie International Edition. 40(19). 3679–3679.
19.
Brown, Nigel, Tracey Young, David Gray, Allan M. Skene, & J R Hampton. (1997). Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ. 315(7101). 159–164.
20.
Simon, Eric J., Rüdiger Gerstberger, & David Gray. (1992). Central nervous angiotensin II responsiveness in birds. Progress in Neurobiology. 39(2). 179–207.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kenneth J. Wilson Breakdown of academic impact, for papers by Carlo Cavallotti Breakdown of academic impact, for papers by Gary W. Small Breakdown of academic impact, for papers by Michiko Takahashi Breakdown of academic impact, for papers by J. Doucet Breakdown of academic impact, for papers by Akira Mizuno Breakdown of academic impact, for papers by Salvatore Magazù Breakdown of academic impact, for papers by Kaoru Nakamura Breakdown of academic impact, for papers by Dávid Becker Breakdown of academic impact, for papers by Klaus Arnold